Today we hear a great deal about Alzheimer’s disease, but relatively little about its discoverer. Its discoverer had little idea how famous his few case studies would become. Here’s how Alzheimer’s went from a medical anomaly to one of the most known and feared medical conditions in the world.
It's bad enough news that Eli Lilly & Co. pulled the plug on an experimental Alzheimer's Disease drug, semagacestat, after dreadful clinical trials. But Lilly's failure makes it more likely Alzheimer's treatment research has been going down a blind alley.